185563-93-3

Basic information

• Product Name: 2-AMINO-1-TRITYL-IMIDAZOLE
• Synonyms: 2-AMINO-1-TRITYL-IMIDAZOLE
• CAS NO: 185563-93-3
• Molecular Formula: C₂₂H₁₉N₃
• Molecular Weight: 0
• Mol File: 185563-93-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-AMINO-1-TRITYL-IMIDAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-1-TRITYL-IMIDAZOLE(185563-93-3)
• EPA Substance Registry System: 2-AMINO-1-TRITYL-IMIDAZOLE(185563-93-3)

Safety Data

• Hazardous Substances Data: 185563-93-3(Hazardous Substances Data)

Usage

Appearance

Pale yellow powder

Melting point

High

Use

Protecting group for amino acids in peptide and protein synthesis

Selectivity

Protects N-terminal amino group of peptides and proteins

Stability

Suitable for various chemical reactions

Role

Crucial in synthesis and manipulation of complex molecules in chemical and biological research

Upstream product

• 185563-92-2 1Triphenylmethyl-2-phthalimidoimidazole 

Downstream Products

• 1037078-72-0 N-(4-fluoro-3-(trifluoromethyl)benzyl)-1-trityl-1H-imidazol-2-amine 
• 185563-94-4 3-Ethoxycarbonyl-5-[4-(1-triphenylmethylimidazol-2-ylamino)butyl]isoxazoline 
• 277315-99-8 D-Ethyl 1-(3-((tert-Butoxy)carbonylamino)propyl)-4-oxo-7-(((1-(triphenylmethyl)imidazole-2-yl)amino)methyl)hydroquinoline-3-carboxylate 
• 258845-39-5 2-(3,5-dichloro-biphenyl-4-sulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-40-8 2-(3,5-dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 185563-99-9 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid tert-butyl ester 
• 258845-37-3 2-(2,6-dichloro-benzenesulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 185564-00-5 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-44-2 2-(biphenyl-4-sulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-42-0 2-(naphthalene-1-sulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-46-4 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-({5-[2-(1-trityl-1H-imidazol-2-ylamino)-ethyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 

Relevant articles and documents

IMPROVED LINKERS FOR ANCHORING TARGETING LIGANDS

An improved linker which lacks chiral centers between a hydrophobic anchor for coupling to lipid-based particles and a targeting agent has suitable hydrophobic/hydrophilic properties for use in vivo.

Integrin receptor antagonists

This invention relates to novel heterocycles including 3-?1-?3-(imidazolin-2-ylamino)propyl!indazol-5-ylcarbonylamino!-2-(benzyloxycarbonylamino)propionic acid, which are useful as antagonists of the αv β3 integrin and related cell surface adhesive protein receptors, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of cell adhesion, the treatment of angiogenic disorders, inflammation, bone degradation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration, and other conditions mediated by cell adhesion and/or cell migration and/or angiogenesis.